NDC 63187-583

Zonisamide

Zonisamide

Zonisamide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Zonisamide.

Product ID63187-583_5c89db99-d1c9-442e-8438-822f667af531
NDC63187-583
Product TypeHuman Prescription Drug
Proprietary NameZonisamide
Generic NameZonisamide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2006-01-30
Marketing CategoryANDA / ANDA
Application NumberANDA077651
Labeler NameProficient Rx LP
Substance NameZONISAMIDE
Active Ingredient Strength100 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Anti-epileptic Agent [EPC],Sulfonamides [CS],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 63187-583-30

30 CAPSULE in 1 BOTTLE (63187-583-30)
Marketing Start Date2018-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63187-583-30 [63187058330]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077651
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-01

NDC 63187-583-90 [63187058390]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077651
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-01

NDC 63187-583-60 [63187058360]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077651
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-01

Drug Details

Active Ingredients

IngredientStrength
ZONISAMIDE100 mg/1

OpenFDA Data

SPL SET ID:85321a9a-08d9-49e4-8c79-86ecfc536613
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 314285
  • Pharmacological Class

    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Anti-epileptic Agent [EPC]
    • Sulfonamides [CS]
    • Carbonic Anhydrase Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Anti-epileptic Agent [EPC]
    • Sulfonamides [CS]
    • Carbonic Anhydrase Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]

    NDC Crossover Matching brand name "Zonisamide" or generic name "Zonisamide"

    NDCBrand NameGeneric Name
    0185-0193ZonisamideZonisamide
    0185-0199ZonisamideZonisamide
    0185-0200ZonisamideZonisamide
    0378-6725Zonisamidezonisamide
    0378-6726Zonisamidezonisamide
    0378-6727Zonisamidezonisamide
    0615-1379Zonisamidezonisamide
    0615-8266zonisamidezonisamide
    21695-155ZONISAMIDEZONISAMIDE
    21695-654ZONISAMIDEZONISAMIDE
    29300-428ZonisamideZonisamide
    29300-429ZonisamideZonisamide
    29300-430ZonisamideZonisamide
    31722-228ZonisamideZonisamide
    33261-843ZONISAMIDEZONISAMIDE
    35356-143ZONISAMIDEZONISAMIDE
    43063-575Zonisamidezonisamide
    43063-932ZonisamideZonisamide
    50090-2174ZonisamideZonisamide
    50268-816ZonisamideZonisamide
    51079-768Zonisamidezonisamide
    51407-137ZonisamideZonisamide
    51407-138ZonisamideZonisamide
    68001-243ZonisamideZonisamide
    68001-242ZonisamideZonisamide
    68001-244ZonisamideZonisamide
    68071-4152ZonisamideZonisamide
    68382-213ZonisamideZonisamide
    68382-212ZonisamideZonisamide
    68382-214ZonisamideZonisamide
    68462-130ZonisamideZonisamide
    68462-129ZonisamideZonisamide
    68462-128ZonisamideZonisamide
    69097-861zonisamidezonisamide
    70518-1701ZonisamideZonisamide
    70771-1142ZonisamideZonisamide
    70771-1144ZonisamideZonisamide
    70771-1143ZonisamideZonisamide
    71335-0486zonisamidezonisamide
    71335-0962ZonisamideZonisamide
    71335-0125ZonisamideZonisamide
    76282-228ZonisamideZonisamide
    51407-139ZonisamideZonisamide
    53217-301zonisamidezonisamide
    55111-288ZonisamideZonisamide
    55111-402ZonisamideZonisamide
    55111-403ZonisamideZonisamide
    55648-990ZONISAMIDEZONISAMIDE
    55648-946ZONISAMIDEZONISAMIDE
    55648-945ZONISAMIDEZONISAMIDE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.